VeriChip Corporation's Infant Protection Systems Now Installed in More Than Half of All Birthing Facilities in Ohio
Pastor Dale Morgan
VeriChip Corporation's Infant Protection Systems Now Installed in More
Than Half of All Birthing Facilities in Ohio
*Wednesday December 12, 8:30 am ET
DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriChip Corporation (Nasdaq:CHIP -
News), a provider of RFID systems for healthcare and patient-related
needs, announced today that the Company’s wholly-owned subsidiary,
Xmark, recently completed a sale of an infant protection system in the
state of Ohio, where Xmark’s infant protection systems are now installed
in more than half of all birthing facilities. This install base features
systems sold under the Company’s HUGS® brand.
“Our HUGS system, which is the industry standard, continues its
sustained growth in maternity wards and birthing centers throughout the
U.S.,” said Daniel A. Gunther, President and CEO of Xmark. “The
expansion of our install base is critical to our ongoing success. From
sales to new hospital customers, replacement systems and upgrades to
existing systems, we are pleased to be the provider of choice for infant
security systems for the majority of hospitals.”
Xmark’s infant protection systems are designed to prevent infant
abductions and inadvertent child mismatching. The main component of the
systems is a wearable RFID tag that is assigned to child and mother
following birth. Monitors positioned throughout the hospital detect the
integrity of the tags and location of the child. If a newborn is removed
from the ward, if the tag is lifted from the baby’s skin or if the ankle
strap is compromised, the system immediately triggers an alarm, alerting
hospital security to the situation.
Xmark infant protection systems also protect against mismatching events
by affixing matching RFID tags to mother and child. If the mother is
given the wrong child, the RFID tag detects the mismatch and activates
an audible alarm.
For more information on Xmark’s products, please contact 1-866-55–XMARK
or email sa...@xmark.com. Additional information can be found online at
www.xmark.com.
About Xmark
Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip
Corporation. For over 25 years, Xmark Corporation has provided Radio
Frequency Identification (RFID) solutions to identify, locate, and
protect people and assets in healthcare environments. Its market-leading
infant protection, wander prevention, personal duress, and asset
tracking applications are trusted by over 5,000 healthcare institutions
worldwide to keep individuals safe.
Xmark products are installed and serviced through an international
network of authorized dealers, backed by a dedicated technical services
department at Xmark. All aspects of Xmark’s business are certified to
the ISO 9001 quality standard.
About VeriChip
VeriChip Corporation, headquartered in Delray Beach, Florida, develops,
markets and sells radio frequency identification, or RFID, systems used
to identify, locate and protect people and assets. VeriChip's goal is to
become the leading provider of RFID systems for people in the healthcare
industry. The Company recently began marketing its VeriMed(TM) Patient
Identification System, a passive RFID system for rapidly and accurately
identifying people who arrive in an emergency room and are unable to
communicate. This system uses the first human-implantable passive RFID
microchip, the implantable VeriChip(TM), cleared for medical use in
October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Solutions Inc.
(Nasdaq:ADSX - News), which also owns a majority position in Digital
Angel Corporation (AMEX:DOC - News). Digital Angel, a leader in RFID and
GPS technologies, owns the patent on the human implantable, passive RFID
microchip and manufactures it for VeriChip. For more information on
VeriChip, please call 1-800-970-2447, or email in...@verichipcorp.com.
Additional information can be found online at http://www.verichipcorp.com.
Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press release
other than historical facts are "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and as that term is defined in the
Private Litigation Reform Act of 1995. Such forward-looking statements
involve risks and uncertainties and are subject to change at any time,
and the Company's actual results could differ materially from expected
results. The Company undertakes no obligation to update forward-looking
statements to reflect subsequently occurring events or circumstances.
Contact:
VeriChip Corporation, Delray Beach
Allison Tomek, 561-805-8008
ato...@adsx.com
or
CEOcast
Dan Schustack, 212-732-4300
Source: VeriChip Corporation